PMID: 2415780
Participants in Tyde Wellnesss programs report an average body weight loss of 15% after 68 weeks, with many achieving weight loss exceeding 20-25% within a year, showcasing the effectiveness of a comprehensive approach to weight management
Diabetes Care 47(8):13501359 Mather KJ, Mari A, Weerakkody G, Heise T, DeVries JH, Urva S, Coskun T, Milicevic Z, Haupt A, Thomas MK (2025) Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis
Improved Glycemic Control Studies show Semaglutide may: Enhance insulin secretion Reduce glucagon release Improve fasting and postprandial glucose stability 3
We take a traditional and functional approach to treatment
Significant effects of HM11260C (efpeglenatide) on body weight over 20 weeks in obese subjects without diabetes: a randomised, double-blind, placebo controlled study [abstract]